Literature DB >> 21627635

Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress.

E M Fekete1, Y Zhao, A Szücs, V Sabino, P Cottone, J Rivier, W W Vale, G F Koob, E P Zorrilla.   

Abstract

BACKGROUND AND
PURPOSE: Infusion of corticotropin-releasing factor (CRF)/urocortin (Ucn) family peptides suppresses feeding in mice. We examined whether rats show peripheral CRF/Ucn-induced anorexia and determined its behavioural and pharmacological bases. EXPERIMENTAL APPROACH: Male Wistar rats (n= 5-12 per group) were administered (i.p.) CRF receptor agonists with different subtype affinities. Food intake, formation of conditioned taste aversion and corticosterone levels were assessed. In addition, Ucn 1- and Ucn 2-induced anorexia was studied in fasted CRF(2) knockout (n= 11) and wild-type (n= 13) mice. KEY
RESULTS: Ucn 1, non-selective CRF receptor agonist, reduced food intake most potently (~0.32 nmol·kg(-1) ) and efficaciously (up to 70% reduction) in fasted and fed rats. The peptides' rank-order of anorexic potency was Ucn 1Ucn 2 > >stressin(1) -A > Ucn 3, and efficacy, Ucn 1 > stressin(1) -A > Ucn 2 = Ucn 3. Ucn 1 reduced meal frequency and size, facilitated feeding bout termination and slowed eating rate. Stressin(1) -A (CRF(1) agonist) reduced meal size; Ucn 2 (CRF(2) agonist) reduced meal frequency. Stressin(1) -A and Ucn 1, but not Ucn 2, produced a conditioned taste aversion, reduced feeding efficiency and weight regain and elicited diarrhoea. Ucn 1, but not Ucn 2, also increased corticosterone levels. Ucn 1 and Ucn 2 reduced feeding in wild-type, but not CRF(2) knockout, mice. CONCLUSIONS AND IMPLICATIONS: CRF(1) agonists, Ucn 1 and stressin(1) -A, reduced feeding and induced interoceptive stress, whereas Ucn 2 potently suppressed feeding via a CRF(2) -dependent mechanism without eliciting malaise. Consistent with their pharmacological differences, peripheral urocortins have diverse effects on appetite.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21627635      PMCID: PMC3246660          DOI: 10.1111/j.1476-5381.2011.01512.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  78 in total

1.  Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain.

Authors:  R K Chan; W W Vale; P E Sawchenko
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2.

Authors:  L Wang; V Martínez; J E Rivier; Y Taché
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-11       Impact factor: 3.619

3.  Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.

Authors:  S Y Hsu; A J Hsueh
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

4.  Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

Authors:  T L Bale; A Contarino; G W Smith; R Chan; L H Gold; P E Sawchenko; G F Koob; W W Vale; K F Lee
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

5.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.

Authors:  K Lewis; C Li; M H Perrin; A Blount; K Kunitake; C Donaldson; J Vaughan; T M Reyes; J Gulyas; W Fischer; L Bilezikjian; J Rivier; P E Sawchenko; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

6.  Urocortin reduces oxygen consumption in lean and ob/ob mice.

Authors:  A Asakawa; A Inui; N Ueno; S Makino; M Fujimiya; M A Fujino; M Kasuga
Journal:  Int J Mol Med       Date:  2001-05       Impact factor: 4.101

7.  Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.

Authors:  T M Reyes; K Lewis; M H Perrin; K S Kunitake; J Vaughan; C A Arias; J B Hogenesch; J Gulyas; J Rivier; W W Vale; P E Sawchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

8.  Urocortin, corticotropin releasing factor-2 receptors and energy balance.

Authors:  M J Cullen; N Ling; A C Foster; M A Pelleymounter
Journal:  Endocrinology       Date:  2001-03       Impact factor: 4.736

9.  Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse.

Authors:  K Van Pett; V Viau; J C Bittencourt; R K Chan; H Y Li; C Arias; G S Prins; M Perrin; W Vale; P E Sawchenko
Journal:  J Comp Neurol       Date:  2000-12-11       Impact factor: 3.215

Review 10.  Urocortin and the brain.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-11-07       Impact factor: 11.685

View more
  13 in total

1.  CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP.

Authors:  Riccardo Dore; Attilio Iemolo; Karen L Smith; Xiaofan Wang; Pietro Cottone; Valentina Sabino
Journal:  Neuropsychopharmacology       Date:  2013-05-09       Impact factor: 7.853

2.  Insula to ventral striatal projections mediate compulsive eating produced by intermittent access to palatable food.

Authors:  Samantha Spierling; Giordano de Guglielmo; Dean Kirson; Alison Kreisler; Marisa Roberto; Olivier George; Eric P Zorrilla
Journal:  Neuropsychopharmacology       Date:  2019-10-08       Impact factor: 7.853

Review 3.  Gray areas: Neuropeptide circuits linking the Edinger-Westphal and Dorsal Raphe nuclei in addiction.

Authors:  Matthew B Pomrenze; Leigh C Walker; William J Giardino
Journal:  Neuropharmacology       Date:  2021-09-02       Impact factor: 5.273

4.  Decreased excitability of leptin-sensitive anterior insula pyramidal neurons in a rat model of compulsive food demand.

Authors:  Dean Kirson; Samantha R Spierling Bagsic; Jiayuan Murphy; Hang Chang; Roman Vlkolinsky; Sarah N Pucci; Julia Prinzi; Casey A Williams; Savannah Y Fang; Marisa Roberto; Eric P Zorrilla
Journal:  Neuropharmacology       Date:  2022-02-02       Impact factor: 5.273

5.  The effects of extended intravenous nicotine administration on body weight and meal patterns in male Sprague-Dawley rats.

Authors:  Patricia E Grebenstein; Ian E Thompson; Neil E Rowland
Journal:  Psychopharmacology (Berl)       Date:  2013-03-14       Impact factor: 4.530

6.  Posttranslational processing of human and mouse urocortin 2: characterization and bioactivity of gene products.

Authors:  Joan M Vaughan; Cynthia J Donaldson; Wolfgang H Fischer; Marilyn H Perrin; Jean E Rivier; Paul E Sawchenko; Wylie W Vale
Journal:  Endocrinology       Date:  2013-03-14       Impact factor: 4.736

Review 7.  Energetic stress: The reciprocal relationship between energy availability and the stress response.

Authors:  C S Harrell; C F Gillespie; G N Neigh
Journal:  Physiol Behav       Date:  2015-10-09

Review 8.  Chronic and acute effects of stress on energy balance: are there appropriate animal models?

Authors:  Ruth B S Harris
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-12-17       Impact factor: 3.619

9.  Regulation of gonadotropins by corticotropin-releasing factor and urocortin.

Authors:  Kazunori Kageyama
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-20       Impact factor: 5.555

10.  The cytokine ciliary neurotrophic factor (CNTF) activates hypothalamic urocortin-expressing neurons both in vitro and in vivo.

Authors:  Matthew J Purser; Prasad S Dalvi; Zi C Wang; Denise D Belsham
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.